Register to get unlimited Level 2

IP Group's Oxford Nanopore in advanced development on SARS Cov-2 test

By Frank Prenesti

Date: Friday 22 May 2020

(Sharecast News) - Intellectual property developer IP Group said its portfolio company Oxford Nanopore Technologies was in advanced development of a new generation of end-to-end test (assay) for the detection of the virus that causes Covid-19.
IP, which holds 16.4% of Oxford Nanopore, said the "LamPORE" test, which finds SARS-CoV-2, is designed to be "rapid, low cost, and scalable to cater to on-demand analysis of smaller sample numbers, to very large numbers of samples".

LamPORE is based on Oxford Nanopore's DNA/RNA sequencing technology and seeks to understand whether a sample currently contains SARS-CoV-2, rather than detecting antibodies that may indicate a previous infection, the company added.


Email this article to a friend

or share it with one of these popular networks:

Top of Page